Signal Projections put 25 million Americans on GLP-1 treatment by 2030
Summary
McKinsey cites a projection that 25 million people in the United States could be taking GLP-1 medications by 2030.
Classification
Main topicBio & Health Tech
Region menusGlobal
Occurrencescope:country · geo_region:north_america · country:US
Impactscope:global
Time horizon4-10 years (2026-07-26)
Last updated2026-07-29 04:49:53
Evidence 2
- State of the Consumer 2026: When tech acceleration and cost pressures collide McKinsey & Company page=9;section=Chapter 2: The health revolution - Wearables and scientific breakthroughs are influencing consumer goals / Footnote 6 2026-06 accessed 2026-07-26
- State of the Consumer 2026: When tech acceleration and cost pressures collide McKinsey & Company page=9;section=Chapter 2: The health revolution - Wearables and scientific breakthroughs are influencing consumer goals 2026-06 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-2e89948ae0bc